Study of the Recovery of Muscle Function in the Arm/Hand After a Stroke

Sponsor
NYU Langone Health (Other)
Overall Status
Completed
CT.gov ID
NCT01422005
Collaborator
Icahn School of Medicine at Mount Sinai (Other)
53
1
2
107.3
0.5

Study Details

Study Description

Brief Summary

The purpose of this study is to examine if practicing joint movements using specially designed devices can help in the recovery of muscle function in the arm/hand after a stroke. Subjects may qualify for participation in this study because they had a stroke and have had difficulty using their affected arm/hand ever since.

Condition or Disease Intervention/Treatment Phase
  • Other: Simultaneous Bimanual training
  • Other: Conventional Occupational Therapy
N/A

Detailed Description

Stroke is a leading cause of long-term adult disability in the United States, and hemiparesis is the most common motor impairment that frequently leads to persistent deficits in hand function. The mechanisms of recovery of hand motor function after stroke are poorly understood, and the protocols used in clinical practice lack a solid scientific rationale. The long-term objective of this research is to understand the neural mechanisms underlying the recovery of voluntary motor functions in brain-injured patients in order to provide a more objective and scientific basis to rehabilitation protocols used in clinical practice.

These devices will be used to facilitate the training of either unimanual or bimanual movements that can be used both in the acute and chronic post-stroke period, even when there is little active movement in the affected upper extremity. The specially designed mechanical devices (BAT, PST and WIFIT), Psychophysical methods using an instrumented glove, and electromyographic recordings from upper extremity muscles to investigate the following specific aims in patients with post-stroke hemiparesis will lead to:

  • greater extensor muscle activation and out of synergy movement compared with unimanual training facilitated by an external agent (e.g. another person).

  • Bimanual training with the specially designed mechanical devices (BAT, PST and WIFIT) over 6 weeks will produce greater functional recovery in the affected upper extremity in patients with post-stroke hemiparesis, compared with conventional therapy.

  • The gains in motor control and function will be greater in patients who begin bimanual training in the acute post-stroke phase (0-6) months, compared with those that begin in the chronic post-stroke phase (> 6 months).

Study Design

Study Type:
Interventional
Actual Enrollment :
53 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Simultaneous Bimanual Training to Improve Motor Function Post-Stroke
Actual Study Start Date :
Jan 1, 2011
Actual Primary Completion Date :
Dec 12, 2019
Actual Study Completion Date :
Dec 12, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental group

Simultaneous Bimanual training: Patients who have had either an acute/subacute and a Chronic stroke will get training on the devices.

Other: Simultaneous Bimanual training
Patients who have had a stroke and are in the Device group will undergo 12 weeks of training using the devices. Patients who have had a stroke and are in the Control group, will undergo 12 weeks of conventional therapy.
Other Names:
  • Device group
  • Control group
  • Active Comparator: Control Group

    Conventional Occupational Therapy: Patients who have had either an acute/subacute and Chronic Stroke with hemiperisis will get conventional therapy.

    Other: Conventional Occupational Therapy
    Conventional Occupational Therapy will be given to patients in the control group.
    Other Names:
  • Control Group
  • Outcome Measures

    Primary Outcome Measures

    1. Measurement of hand function [Day 1]

      The outcome measures using the devices will include: hand function range of motion stiffness extent of impairment on the affected side temperature differences between the two sides of the body, and skin sensitivity to pressure. Testing of independent finger movements and grasp-release during a functional task will be measured using an instrumented glove with concurrent electromyographic and 3-D Motion analysis of joint movements and muscle activity patterns.

    Secondary Outcome Measures

    1. Measurement of Hand Function [Day 84]

      The outcome measures using the devices will include: hand function range of motion stiffness extent of impairment on the affected side temperature differences between the two sides of the body, and skin sensitivity to pressure. Testing of independent finger movements and grasp-release during a functional task will be measured using an instrumented glove with concurrent electromyographic and 3-D Motion analysis of joint movements and muscle activity patterns.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    21 Years to 75 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Ability to follow study instructions and likely to complete all required visits; ability to comply with the therapy protocol as assessed by the investigator; must be English speaking.

    • Subjects must have had a unilateral stroke

    Exclusion Criteria:
    • Severe upper extremity spasticity suggested by an Ashworth score of >3 at any joint, or restriction of full passive range of motion.

    • Evidence of alcohol, drug abuse or other relevant neuropsychiatric condition such as psychotic illness or severe depression.

    • Any condition or situation that, in the investigator's opinion, may put the subject at significant risk, confound the study results, or interfere significantly with the subject's participation in the study.

    • History of surgery or other significant injury to either upper extremity causing mechanical limitations that preclude task performance.

    • Previous neurological illness such as head trauma, prior stroke, epilepsy, or demyelinating disease.

    • Complicating medical problems such as uncontrolled hypertension, diabetes with signs of polyneuropathy, severe renal, cardiac or pulmonary disease, or evidence of other concurrent neurologic or orthopedic conditions precluding the subject from complying with the study protocol

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 New York Univeristy School of Medicine New York New York United States 10016

    Sponsors and Collaborators

    • NYU Langone Health
    • Icahn School of Medicine at Mount Sinai

    Investigators

    • Principal Investigator: John R Rizzo, MD, New York Univeristy School of Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    NYU Langone Health
    ClinicalTrials.gov Identifier:
    NCT01422005
    Other Study ID Numbers:
    • 11-00118
    • R#: 11-00118
    First Posted:
    Aug 23, 2011
    Last Update Posted:
    Aug 19, 2020
    Last Verified:
    Aug 1, 2020

    Study Results

    No Results Posted as of Aug 19, 2020